• Aucun résultat trouvé

Allogeneic hematopoietic cell transplantation

Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

... Thomas’ Hematopoietic Cell Trans- ...Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized ...after allogeneic ...

7

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

... after allogeneic hematopoietic cell transplantation (HCT) has remained unclear thus ...given allogeneic hemato- poietic stem cells after either nonmyeloablative (n ¼ 176) or high-dose ...

5

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

... by allogeneic hematopoietic cell transplantation (HCT) has been recognized as an effective therapy for a number of hematologic malignancies with tumor cells resistant to conventional doses of ...

26

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.

... llogeneic hematopoietic cell transplantation (HCT) after a high-dose myeloablative conditioning regimen has been an eff ective treatment for many patients with hematologic ...of allogeneic HCT ...

15

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

... 1 Transplantation Biology Programme, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 2 Department of Hematology, University of Lie`ge, Lie`ge, Belgium and 3 Department of ...

11

Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

... that allogeneic hematopoietic stem cell transplantation (HSCT) might possibly serve to consolidate the response to initial ...stem cell transplantation ...

5

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

... after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 Donor lymphocyte infusion (DLI) has become standard therapy for relapse after ...

2

View of Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation

View of Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation

... · Allogeneic hematopoietic stem cell transplantation Introduction L ’allogreffe de cellules souches hématopoïétiques (ACSH) constitue un traitement curatif de différentes pathologies ...

8

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

... Renal cell carcinoma (RCC) is particularly sensitive to immune ...after hematopoietic stem cell transplantation (HSCT), in particular the 14 bp insertion/deletion polymorphism in the 3 ′ ...

6

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Stud

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

... received transplantation in CR2, a Karnofsky performance score of 90, diagnosed with acute myeloid leukemia, received transplantation from a matched unrelated donor (MUD) in 2011, and both recipient and ...

10

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...given allogeneic hematopoietic cell transplanta- tion after nonmyeloablative ...to ...

7

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

... alloSCT, allogeneic hematopoietic stem cell transplan- tation; AML, acute myelogenous leukemia; BM, bone marrow; CGD, chronic granulomatous disease; CI, confidence interval; CML, chronic myeloid ...

10

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

... of allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...and cell surface recognition molecules by host cells and thereby enhancing the recognition of host minor or major ...

9

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

... performing allogeneic hematopoietic stem cell transplantation (HSCT) in patients for whom conventional myeloablative allogeneic HSCT would have been associ- ated with unacceptable risks ...

7

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study

... after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l’Enfant et de L’Adolescent Study Sandrine Visentin, Pascal Auquier, Yves Bertrand, André ...

30

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

... marrow transplantation [ 6 – 9 ...T cell dysfunction and promoting graft tolerance [ 14 ...stem cell graft sources with GVHD and relapse incidence rates ...

12

Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.

Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.

... Figure 1. Evolution of sjTREC concentration according to patient age at HCT. CD4+CD45RA+) counts (P<0.0001). An inverse correlation was observed between the levels of sjTREC/ml and the recipient's age (R=-0.41, ...

2

Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age

Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age

... Patients and donors Data from 80 patients transplanted between March 2000 and April 2008 at the University of Liège were included in the study. Results were analyzed as of July 29, 2009. Patients’ characteristics are ...

9

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.

... Statistical analysis To ensure better homogeneity of the results, Hb, sTfR, and retic- ulocytes were normalized relative to their value on the day of transplantation. Unpaired and paired Student’s t-tests as well ...

10

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *

... The primary objective of this study was to study the impact of iron overload and iron toxicity on out- come after HSCT. As expected [ 21 ], the data showed a significant association between transfusion burden and ...

13

Show all 4102 documents...

Sujets connexes